Viewing nowCombinationRisendex-M Tablet (Risedronate Sodium 2.5 Hydrate, Cholecalciferol)
Risedronate Sodium 2.5 Hydrate 172.1mg · Cholecalciferol 0.75mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 201202526 · Approved 2012.04.03 · Insurance code 645304450
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used for the treatment and prevention of osteoporosis in postmenopausal women.
1. Adults: Take 1 tablet of this drug orally once a month. 2. Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this drug in older adults (60 years and older) are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary for patients with creatinine clearance of 30ml/min or higher. This drug is contraindicated in patients with severe renal impairment and creatinine clearance below 30ml/min. Food interferes with absorption of this drug; for adequate absorption, take it at least 30 minutes before consuming the first food or beverage other than water of the day. To help this drug reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. Patients should take supplements if their dietary intake of calcium and vitamin D is inadequate. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, residents of nursing homes, and patients with chronic diseases) may require additional vitamin D supplements. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D concentrations should be considered. The recommended daily intake of vitamin D is 400IU to 800IU. One monthly dose of this drug provides a month's supply of vitamin D at 1000IU daily. If a patient forgets to take this drug on the scheduled day, follow these instructions: - If the next scheduled dose is at least 7 days away, take 1 tablet the next morning after remembering. Take the next dose on the originally scheduled day. Do not take more than 1 tablet of this drug within 7 days. - If the next scheduled dose is within 7 days, wait until the originally scheduled day and then take 1 tablet of this drug.
3. Children: Safety and efficacy have not been established in children and adolescents who are still growing.
This drug can irritate the gastric mucosa and may cause esophageal adverse reactions such as esophagitis, esophageal ulcers, and esophageal erosion. It should be taken with a sufficient amount of water after ingestion, and you should not lie down for more than 30 minutes after taking it. If you experience symptoms such as difficulty swallowing, pain behind the breastbone, or heartburn, you should stop taking the medication immediately and consult your doctor. This drug should not be taken by patients with esophageal strictures, hypocalcemia, pregnant or breastfeeding women, or patients with severe renal dysfunction. Be careful not to take this medication with drugs or foods containing calcium, magnesium, or iron, and it is recommended to take this medication on an empty stomach. This medication is used for the treatment of osteoporosis, and appropriate intake of calcium and vitamin D is important. You should consult your doctor before dental treatment, as serious side effects such as osteonecrosis of the jaw can occur rarely. Elderly patients can generally take this medication safely, but any adverse reactions should be reported to healthcare providers immediately. In case of overdose, symptoms of hypocalcemia may occur, and you should visit a medical facility immediately for treatment, which may include calcium supplementation. This medication is not recommended for pregnant or breastfeeding women, and if you are planning to become pregnant or are pregnant, you should consult your doctor. It is very important to strictly adhere to the prescribed dosage and directions from your doctor when taking this medication.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is safe to store at a temperature between 1 degrees and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and prevent degradation.
Blue oval film-coated tablet
1 tablet (1 tablet/PTP packaging X 1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRisedronate Sodium 2.5 Hydrate 172.1mg · Cholecalciferol 0.75mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 172.1mg · Cholecalciferol 0.75mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRisedronate Sodium 2.5 Hydrate 172.1mg · Cholecalciferol 0.75mg
Tablet · Prescription medication · Combination
DongKook Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.